“…The high rate of suppression in our study was in accord with the results of studies comparing the abacavir–zidovudine–lamivudine with unboosted protease-inhibitor–based HAART 14,15. Unlike some previous studies,14,16 treatment with abacavir–zidovudine–lamivudine was as effective as other HAART regimens when the baseline HIV-1 RNA level was more than 100,000 copies per milliliter. Rates of suppression with nevirapine-based HAART in the observational group were also high, despite more advanced disease and more toxic effects requiring treatment modification among women in this group.…”